Kaplan Andrew T.
- SEC CIK
- 0001752059
In the past year, 1 open-market purchase filing worth $134.4M and no sales.
Current role at each company
- KLRA Kailera Therapeutics, Inc.Director, 10% Owneras of Apr 20, 2026
- SGRY Surgery Partners, Inc.Director, 10% Owneras of Dec 21, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- $134.4M
- 1 filing
- Sold
- –
- 0 filings
- Net
- +$134.4M
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Kaplan Andrew T. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
KLRA Kailera Therapeutics, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2026 (view filing) | Apr 20 | Same day | Kaplan Andrew T.Director, 10% Owner | PPurchase | +8.40M | $16.00 | +$134.4M | +47.0%26.3M after |
SGRY Surgery Partners, Inc.
Director, 10% Owner1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2023 (view filing) | Dec 19 | 2 days | Kaplan Andrew T.Director, 10% Owner | SSale | −7.83M | $33.44 | −$261.7M | −13.4%50.4M after | Duplicate filing |